Molecular Imaging in Oncocardiology

Nagara Tamaki*; Tomoya Kotani; Shigenori Matsushima; Toshiyuki Okamoto; Kan Zen; Kei Yamada

**Nagara Tamaki*, Tomoya Kotani, Shigenori Matsushima, Toshiyuki Okamoto, Kan Zen and Kei Yamada**

Volume4-Issue1
Dates: Received: 2022-12-23 | Accepted: 2022-12-28 | Published: 2023-01-04
Pages: 001-004

Abstract

Cancer and Cardiovascular Disease (CVD) are the most common causes of death and disability in many countries. Cancer and CVD are closely related in terms of both scientific and clinical perspectives. Oncocardiology has recently gained attention by oncologists, cardiologists, and radiologists for mutual work on pathophysiology analysis and treatment strategy [1-3]. In various clinical settings, these specialists may collaborate in the diagnosis and treatment of cancer patients with cardiovascular disease.

FullText HTML FullText PDF DOI: 10.37871/jbres1641

Certificate of Publication

Copyright

How to cite this article

Tamaki N, Kotani T, Matsushima S, Okamoto T, Zen K, Yamada K. Molecular Imaging in Oncocardiology. 2022 Jan 04; 4(1): 001-004. doi: 10.37871/jbres1641, Article ID: JBRES1641, Available at: https://www.jelsciences.com/articles/ jbres1641.pdf

Subject area(s)

Oncology

Clinical Cardiology

References

Yeh ET, Chang HM. Oncocardiology-Past, Present, and Future: A Review. JAMA Cardiol. 2016 Dec 1;1(9):1066-1072. doi: 10.1001/jamacardio.2016.2132. PMID: 27541948; PMCID: PMC5788289.
Sueta D, Tabata N, Akasaka T, Yamashita T, Ikemoto T, Hokimoto S. The dawn of a new era in onco-cardiology: The Kumamoto Classification. Int J Cardiol. 2016 Oct 1;220:837-41. doi: 10.1016/j.ijcard.2016.06.330. Epub 2016 Jul 1. PMID: 27394984.
Okura Y, Ozaki K, Tanaka H, Takenouchi T, Sato N, Minamino T. The Impending Epidemic of Cardiovascular Diseases in Patients With Cancer in Japan. Circ J. 2019 Oct 25;83(11):2191-2202. doi: 10.1253/circj.CJ-19-0426. Epub 2019 Sep 18. PMID: 31534064.
Michel L, Rassaf T, Totzeck M. Cardiotoxicity from immune checkpoint inhibitors. Int J Cardiol Heart Vasc. 2019 Sep 7;25:100420. doi: 10.1016/j.ijcha.2019.100420. PMID: 31517036; PMCID: PMC6736791.
Lyon AR, Yousaf N, Battisti NML, Moslehi J, Larkin J. Immune checkpoint inhibitors and cardiovascular toxicity. Lancet Oncol. 2018 Sep;19(9):e447-e458. doi: 10.1016/S1470-2045(18)30457-1. PMID: 30191849.
Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ET, Shore RE. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):656-65. doi: 10.1016/j.ijrobp.2009.09.064. PMID: 20159360; PMCID: PMC3910096.
Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F; ESMO Guidelines Working Group. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012 Oct;23 Suppl 7:vii155-66. doi: 10.1093/annonc/mds293. PMID: 22997448.
Chavez-MacGregor M, Niu J, Zhang N, Elting LS, Smith BD, Banchs J, Hortobagyi GN, Giordano SH. Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer. J Clin Oncol. 2015 Jul 1;33(19):2176-83. doi: 10.1200/JCO.2014.58.9465. Epub 2015 May 11. PMID: 25964256; PMCID: PMC4979214.
Cunningham CH, Lau JY, Chen AP, Geraghty BJ, Perks WJ, Roifman I, Wright GA, Connelly KA. Hyperpolarized 13C Metabolic MRI of the Human Heart: Initial Experience. Circ Res. 2016 Nov 11;119(11):1177-1182. doi: 10.1161/CIRCRESAHA.116.309769. Epub 2016 Sep 15. PMID: 27635086; PMCID: PMC5102279.
Mahjoob MP, Sheikholeslami SA, Dadras M, Mansouri H, Haghi M, Naderian M, Sadeghi L, Tabary M, Khaheshi I. Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity. Cardiovasc Hematol Disord Drug Targets. 2020;20(1):74-83. doi: 10.2174/1871529X19666190912150942. PMID: 31513000.
Zhao R, Shu F, Zhang C, Song F, Xu Y, Guo Y, Xue K, Lin J, Shu X, Hsi DH, Cheng L. Early Detection and Prediction of Anthracycline-Induced Right Ventricular Cardiotoxicity by 3-Dimensional Echocardiography. JACC CardioOncol. 2020 Mar 17;2(1):13-22. doi: 10.1016/j.jaccao.2020.01.007. PMID: 34396205; PMCID: PMC8352081.
Kim H, Chung WB, Cho KI, Kim BJ, Seo JS, Park SM, Kim HJ, Lee JH, Kim EK, Youn HJ. Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography. J Cardiovasc Ultrasound. 2018 Mar;26(1):1-25. doi: 10.4250/jcu.2018.26.1.1. Epub 2018 Mar 28. PMID: 29629020; PMCID: PMC5881080.
Michel L, Schadendorf D, Rassaf T. Oncocardiology: new challenges, new opportunities. Herz. 2020 Nov;45(7):619-625. doi: 10.1007/s00059-020-04951-x. PMID: 32514587; PMCID: PMC7278757.
de Roos A. Onco-Cardiology: Value of Cardiac Imaging by Using CT and MRI after Radiation Therapy. Radiology. 2018 Nov;289(2):355-356. doi: 10.1148/radiol.2018181039. Epub 2018 Jul 10. PMID: 29989517.
Juneau D, Erthal F, Alzahrani A, Alenazy A, Nery PB, Beanlands RS, Chow BJ. Systemic and inflammatory disorders involving the heart: the role of PET imaging. Q J Nucl Med Mol Imaging. 2016 Dec;60(4):383-96. Epub 2016 Sep 9. PMID: 27611707.
Totzeck M, Aide N, Bauersachs J, Bucerius J, Georgoulias P, Herrmann K, Hyafil F, Kunikowska J, Lubberink M, Nappi C, Rassaf T, Saraste A, Sciagra R, Slart RHJA, Verberne H, Rischpler C. Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging. 2022 Nov 5. doi: 10.1007/s00259-022-05991-7. Epub ahead of print. Erratum in: Eur J Nucl Med Mol Imaging. 2022 Nov 21;: PMID: 36334105.
Nensa F, Kloth J, Tezgah E, Poeppel TD, Heusch P, Goebel J, Nassenstein K, Schlosser T. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI. J Nucl Cardiol. 2018 Jun;25(3):785-794. doi: 10.1007/s12350-016-0616-y. Epub 2016 Sep 8. PMID: 27638745.
Scholtens AM, Verberne HJ, Budde RP, Lam MG. Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in ¹⁸F-FDG PET Imaging. J Nucl Med. 2016 Apr;57(4):568-73. doi: 10.2967/jnumed.115.166884. Epub 2015 Dec 10. PMID: 26659348.
Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, Yamada A, Oyama-Manabe N, Hirata K, Nishimura M, Tamaki N. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016 Apr;23(2):244-52. doi: 10.1007/s12350-015-0226-0. Epub 2015 Aug 5. PMID: 26243179; PMCID: PMC4785205.
Juneau D, Erthal F, Alzahrani A, Alenazy A, Nery PB, Beanlands RS, Chow BJ. Systemic and inflammatory disorders involving the heart: the role of PET imaging. Q J Nucl Med Mol Imaging. 2016 Dec;60(4):383-96. Epub 2016 Sep 9. PMID: 27611707.
Tam MC, Patel VN, Weinberg RL, Hulten EA, Aaronson KD, Pagani FD, Corbett JR, Murthy VL. Diagnostic Accuracy of FDG PET/CT in Suspected LVAD Infections: A Case Series, Systematic Review, and Meta-Analysis. JACC Cardiovasc Imaging. 2020 May;13(5):1191-1202. doi: 10.1016/j.jcmg.2019.04.024. Epub 2019 Jul 17. PMID: 31326483; PMCID: PMC6980257.
Manabe O, Naya M, Aikawa T, Tamaki N. Recent advances in cardiac positron emission tomography for quantitative perfusion analyses and molecular imaging. Ann Nucl Med. 2020 Oct;34(10):697-706. doi: 10.1007/s12149-020-01519-x. Epub 2020 Sep 11. PMID: 32915386.
Kim J, Cho SG, Kang SR, Yoo SW, Kwon SY, Min JJ, Bom HS, Song HC. Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity. J Nucl Cardiol. 2020 Dec;27(6):2154-2163. doi: 10.1007/s12350-019-01617-y. Epub 2019 Feb 4. PMID: 30719656.
Herrmann J. Vascular toxic effects of cancer therapies. Nat Rev Cardiol. 2020 Aug;17(8):503-522. doi: 10.1038/s41569-020-0347-2. Epub 2020 Mar 26. PMID: 32218531; PMCID: PMC8782612.
Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, Yates D, LaMuraglia GM, Furie K, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006 Nov 7;48(9):1818-24. doi: 10.1016/j.jacc.2006.05.076. Epub 2006 Oct 17. PMID: 17084256.
Bucerius J, Hyafil F, Verberne HJ, Slart RH, Lindner O, Sciagra R, Agostini D, Übleis C, Gimelli A, Hacker M; Cardiovascular Committee of the European Association of Nuclear Medicine (EANM). Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis. Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):780-92. doi: 10.1007/s00259-015-3259-3. Epub 2015 Dec 17. PMID: 26678270; PMCID: PMC4764627.
Ripa RS, Hag AM, Knudsen A, Loft A, Specht L, Kjær A. (18)F-FDG PET imaging in detection of radiation-induced vascular disease in lymphoma survivors. Am J Nucl Med Mol Imaging. 2015 Jun 15;5(4):408-15. PMID: 26269778; PMCID: PMC4529594.
Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205-11. doi: 10.1056/NEJM198207223070401. PMID: 6283349.
Schofer J, Spielmann R, Schuchert A, Weber K, Schlüter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1988 Nov;12(5):1252-8. doi: 10.1016/0735-1097(88)92608-3. PMID: 3170968.
Henderson EB, Kahn JK, Corbett JR, Jansen DE, Pippin JJ, Kulkarni P, Ugolini V, Akers MS, Hansen C, Buja LM, et al. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988 Nov;78(5 Pt 1):1192-9. doi: 10.1161/01.cir.78.5.1192. PMID: 3180378.
Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med. 1989 Jul;30(7):1182-91. PMID: 2661758.
Verberne HJ, Verschure DO. Anthracycline-induced cardiotoxicity: Is there a role for myocardial 123I-mIBG scintigraphy? J Nucl Cardiol. 2020 Jun;27(3):940-942. doi: 10.1007/s12350-018-01584-w. Epub 2019 Jan 2. PMID: 30603895.